The role of stressor intensity in influencing the course of heart disease in cardiomyopathic hamsters

Proceedings of the Society for Experimental Biology and Medicine

Volumn 212, Issue 3, 1996, Pages 248-255

  Chang, Qiang ^a,b,c   Natelson, Benjamin H ^a,b   Ottenweller, John E ^a,b   Conway, Robert S ^d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b University of Medicine and Dentistry of New Jersey   (United States)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^d ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BLOOD VESSEL REACTIVITY; CARDIOMYOPATHY; COLD STRESS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY SPASM; DISEASE COURSE; HAMSTER; IMMOBILIZATION; NONHUMAN;

ANIMALIA; CRICETINAE;

EID: 0029984087     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-212-44013     Document Type: Article

References (19)

1. Gertz EW. Cardiomyopathic Syrian hamster: A possible model of human disease. Prog Exp Tumor Res 16:242-250, 1972.
2. Factor SM, Minase T, Cho S, Dominitz R, Sonnenblick EH. Microvascular spasm in the cardiomyopathic Syrian hamster: A preventable cause of focal myocardial necrosis. Circulation 66:342-354, 1982.
3. Figulla HR, Vetterlein F, Glaubitz M, Kreuzer H. Inhomogenous capillary flow and its prevention by verapamil and hydralazine in the cardiomyopathic Syrian hamster. Circulation 76:208-216, 1987.
4. Conway RS, Natelson BH, Chen WH, Ting W. Enhanced coronary vasoconstriction in the Syrian myopathic hamster supports the microvascular spasm hypothesis. Cardiovasc Res 28:320-324, 1994.
5. Ottenweller JE, Tapp WN, Chen TS, Natelson BH. Cardiovascular aging in Syrian hamsters: Similarities between normal aging and disease. Exp Aging Res 13:73-84, 1987.
6. Tapp WN, Natelson BH. Consequences of stress: A multiplicative function of health status. FASEB J 2:2268-2271, 1988.
7. Tapp WN, Natelson BH, Creighton D, Khazam C, Ottenweller JE. Alprazolam reduces stress-induced mortality in cardiomyopathic hamsters. Pharmacol Biochem Behav 32:331-336, 1989.
8. Tapp WN, Natelson BH, Grover E, Ottenweller JE. Alprazolam but not diazepam protects hamsters with heart disease from the medical consequences of stress. Pharmacol Biochem Behav 33:633-636, 1989.
9. Natelson BH, Tapp WN, Drastal S, Suarez R, Ottenweller JE. Hamsters with coronary vasospasm are at increased risk from stress. Psychosom Med 53:322-331, 1991.
10. Walker BR, Childs ME, Adams EM. Direct cardiac effects of vasopressin: Role of V1 and V2 vasopressinergic receptors. Am J Physiol 255:H261-H265, 1988.
11. Weiss JL, Frederiksen JW, Weisfeldt ML. Hemodynamics determinants of the time course of fall in canine left ventricular pressure. J Clin Invest 58(3):751-760, 1976.
12. Kirk RE. Experimental Design: Procedures for the Behavioral Sciences. Monterey, CA: Brooks/Cole, 1982.
13. Litwin SE, Grossman W. Diastolic dysfunction as a cause of heart failure. J Am Coll Cardiol 22(Suppl A):49A-55A, 1993.
14. Mirsky I, Pfeffer JM, Pfeffer MA, Braunwald E. The contractile state as the major determinant in the evolution of left ventricular dysfunction in the spontaneously hypertensive rat. Circ Res 53:767-778, 1983.
15. Factor SM, Sonnenblick EH. The pathogenesis of clinical and experimental congestive cardiomyopathy: recent concepts. Prog Cardiovasc Dis 27:395-420, 1985.
16. Epstein SE, Cannon RO. Site of increased resistance to coronary flow in patients with angina pectoris and normal epicardial coronary arteries. J Am Coll Cardiol 8:459-461, 1986.
17. Cannon RO, Cunnion RE, Parrillo JE, Palmeri ST, Tucker EE, Schenke WH, Epstein SE. Dynamic limitation of coronary vasodilator reserve in patients with dilated cardiomyopathy and chest pain. J Am Coll Cardiol 10:1190-1200, 1987.
18. Cannon RO, Dilsizian V, Correa R, Epstein SE, Bonow RO. Chronic deterioration in left ventricular function in patients with microvascular angina. J Am Coll Cardiol 17:28A, 1991.
19. Opherk D, Schuler G, Wetterauer K, Manthey J, Schwarz F, Kubler W. Four-year follow up study in patients with angina pectoris and normal coronary arteriograms (Syndrome X). Circulation 80:1610-1616, 1989.